DEFA14A: Masimo CEO Discusses Apple Legal Battle, Google Partnership, and Proxy Fight with Politan

Masimo's CEO, Joe Kiani, discusses the company's legal battle with Apple, its partnership with Google, and the ongoing proxy fight with Politan Capital Management.

Summary

• Masimo's CEO, Joe Kiani, discussed the company's legal battle with Apple over blood oxygen detection technology.
• Masimo has partnered with Google and Qualcomm to develop a reference platform for smartwatches with biosensing capabilities.
• Kiani believes Masimo competes based on 'good science', offering continuous accurate SpO2, pulse rate, and hydration measurement.
• Masimo has an injunction against Apple selling SpO2 in the US and a trade secret case that could lead to a broader injunction.
• A patent case could result in a worldwide injunction against Apple regarding photoplethysmography.
• Masimo is excited about its partnership with Google, which will bring scientifically based, continuous, accurate wearables to Android users.
• Kiani addressed the proxy battle with Politan, highlighting that Politan was found to have lied to shareholders and held in contempt by a federal judge.
• Masimo believes it has done everything right morally and legally, bringing the business through COVID and securing the Google partnership.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to the Google partnership and the potential for broader injunctions against Apple. However, the ongoing legal battles and proxy fight introduce uncertainty.

Positives

• Masimo has partnered with Google and Qualcomm to expand its biosensing technology to more smartwatches.
• Masimo's technology offers continuous accurate SpO2, pulse rate, hydration measurement, and pulse rate variability.
• Masimo has an injunction against Apple selling SpO2 in the US.
• Masimo is developing a reference design with Google to bring accurate wearables to Android users.
• A federal judge found that Politan lied to Masimo's shareholders and held them in contempt.

Negatives

• Masimo is engaged in a legal battle with Apple, which could be costly and time-consuming.
• Masimo is involved in a proxy fight with Politan, which could lead to management distraction and uncertainty.
• Apple's products may compete with Masimo's offerings in the health and wellness space.

Risks

• Uncertainties regarding the litigation with Apple and Politan.
• Potential actions by Politan in furtherance of its nomination of director candidates.
• The cost and management distraction associated with the proxy fight and litigation.
• The risk factors discussed in Masimo's most recent periodic reports filed with the SEC.

Future Outlook

Masimo anticipates a slew of products from luxury products to smart watches from the typical Android world that will be an incredible offering for our mutual customers in the next couple of years due to the Google partnership.

Management Comments

• Joe Kiani: 'We compete based on good science. We have continuous accurate SpO2, pulse rate. We can even measure hydration, pulse rate variability, and nobody else has that.'
• Joe Kiani: 'Every Android user now can have a real, scientifically based, continuous, accurate wearable with this reference design were creating with them.'

Industry Context

The announcement highlights the increasing competition in the wearable health technology market, with Masimo positioning itself against Apple and partnering with Google to expand its reach in the Android ecosystem. The legal battle with Apple underscores the importance of intellectual property in this space.

Comparison to Industry Standards

• Apple's entry into health monitoring with the Apple Watch has set a high bar for consumer expectations, but Masimo claims superior accuracy in SpO2 and other measurements.
• Companies like Fitbit and Garmin also offer health tracking features, but Masimo emphasizes its scientifically based approach and continuous monitoring capabilities.
• Masimo's partnership with Google aims to provide a competitive alternative to Apple's health features on Android devices.

Legal Proceedings

• Masimo is engaged in a legal battle with Apple over blood oxygen detection technology.
• Masimo is in litigation against Politan Capital Management LP.

Stakeholder Impact

• Shareholders are impacted by the proxy fight with Politan and the potential outcomes of the litigation.
• Employees are affected by the uncertainty surrounding the proxy fight and the company's strategic direction.
• Customers may benefit from the partnership with Google, which could lead to more accurate and reliable wearable health technology.
• Suppliers and creditors are indirectly affected by the company's financial performance and strategic decisions.

Next Steps

• The 2024 Annual Meeting of Stockholders.
• Potential rehearing of the trade secret case against Apple.
• Potential patent case against Apple.
• Continued development of the reference design with Google.

Key Dates

Keywords

Masimo, Apple, Politan, Google, smartwatch, biosensing, SpO2, injunction, proxy fight, litigation, wearable technology, health technology